Mono Pharmacare Limited (NSE:MONOPHARMA)
24.10
+0.60 (2.55%)
At close: Sep 12, 2025
Mono Pharmacare Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Cash & Equivalents | 6.98 | 3.63 | 4.18 | 2.45 | 1.73 | Upgrade |
Cash & Short-Term Investments | 6.98 | 3.63 | 4.18 | 2.45 | 1.73 | Upgrade |
Cash Growth | 92.33% | -13.17% | 70.70% | 41.28% | -51.25% | Upgrade |
Accounts Receivable | 418.88 | 315.9 | 218.71 | 55.21 | 53.47 | Upgrade |
Receivables | 418.88 | 315.9 | 218.71 | 55.21 | 53.47 | Upgrade |
Inventory | 553.86 | 422.93 | 326.86 | 47.14 | 41.41 | Upgrade |
Other Current Assets | 110.16 | 59.18 | 61.33 | 36.07 | 11.73 | Upgrade |
Total Current Assets | 1,090 | 801.64 | 611.07 | 140.86 | 108.34 | Upgrade |
Property, Plant & Equipment | 9.72 | 8.86 | 8.26 | 2.97 | 3.91 | Upgrade |
Long-Term Investments | - | - | 5.73 | - | - | Upgrade |
Other Intangible Assets | 0.2 | 0.27 | 0.01 | - | - | Upgrade |
Long-Term Deferred Tax Assets | 0.45 | 0.12 | 0.53 | - | - | Upgrade |
Other Long-Term Assets | 0.31 | 0.25 | 0.15 | - | - | Upgrade |
Total Assets | 1,101 | 811.13 | 625.74 | 143.83 | 112.25 | Upgrade |
Accounts Payable | 187.98 | 96.85 | 69.37 | 33.46 | 12.55 | Upgrade |
Accrued Expenses | 18.66 | 8.04 | 3.91 | 0.98 | 1.22 | Upgrade |
Short-Term Debt | 275.99 | 243.16 | 246.02 | 49.26 | 50.95 | Upgrade |
Current Income Taxes Payable | 15.39 | 6.08 | 8.87 | 1.96 | 0.72 | Upgrade |
Other Current Liabilities | 29.74 | 4.04 | 7.43 | 0.28 | 0 | Upgrade |
Total Current Liabilities | 527.76 | 358.17 | 335.61 | 85.94 | 65.43 | Upgrade |
Long-Term Debt | 259.61 | 171.25 | 153.25 | 15.14 | 9.86 | Upgrade |
Other Long-Term Liabilities | -0 | -0 | - | 0 | -0 | Upgrade |
Total Liabilities | 788.21 | 529.84 | 488.85 | 101.07 | 75.29 | Upgrade |
Common Stock | 176.69 | 176.69 | 123.69 | 42.76 | 36.96 | Upgrade |
Additional Paid-In Capital | 74.56 | 74.56 | 4.89 | - | - | Upgrade |
Retained Earnings | 60.74 | 29.84 | 8.28 | - | - | Upgrade |
Total Common Equity | 311.99 | 281.09 | 136.86 | 42.76 | 36.96 | Upgrade |
Minority Interest | 0.35 | 0.19 | 0.03 | - | - | Upgrade |
Shareholders' Equity | 312.34 | 281.28 | 136.89 | 42.76 | 36.96 | Upgrade |
Total Liabilities & Equity | 1,101 | 811.13 | 625.74 | 143.83 | 112.25 | Upgrade |
Total Debt | 535.6 | 414.4 | 399.27 | 64.39 | 60.8 | Upgrade |
Net Cash (Debt) | -528.63 | -410.78 | -395.09 | -61.95 | -59.07 | Upgrade |
Net Cash Per Share | -29.92 | -26.76 | -69.75 | -12.60 | -12.01 | Upgrade |
Filing Date Shares Outstanding | 17.67 | 17.66 | 12.37 | 4.92 | 4.92 | Upgrade |
Total Common Shares Outstanding | 17.67 | 17.66 | 12.37 | 4.92 | 4.92 | Upgrade |
Working Capital | 562.12 | 443.47 | 275.46 | 54.93 | 42.9 | Upgrade |
Book Value Per Share | 17.66 | 15.92 | 11.06 | 8.69 | 7.52 | Upgrade |
Tangible Book Value | 311.79 | 280.82 | 136.85 | 42.76 | 36.96 | Upgrade |
Tangible Book Value Per Share | 17.65 | 15.90 | 11.06 | 8.69 | 7.52 | Upgrade |
Buildings | 4.6 | 4.57 | 4.7 | - | - | Upgrade |
Machinery | 8.94 | 6.86 | 5.19 | 6.43 | 6.29 | Upgrade |
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.